@Marco_Blanker SAF>2.9 geeft 4x zo hoge kans op T2D als waarde <1.9; risico loopt geleidelijk op met hogere SAF. Iedere punt hogere uitslag van SAF (univariaat, range 0.8-4.5) verhoogt kans op T2D met factor 2.7, kans op overlijden met factor 5.1. Zi
Very interesting https://t.co/Ay1TfTP2hd
AGEは糖尿病患者の死を予測するバイオマーカーである #AGE https://t.co/rS81XIsRr6
RT @HelmholtzMucEn: Dutch study shows: Skin autofluorescence predicts incident #type2diabetes, #cardiovasculardisease and #mortality in the…
Dutch study shows: Skin autofluorescence predicts incident #type2diabetes, #cardiovasculardisease and #mortality in the general population @LifelinesNL @medtrib @DiabetologiaJnl https://t.co/LGRyTeZh3s
RT @profsmarshall: Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE read…
RT @profsmarshall: Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE read…
RT @profsmarshall: Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE read…
RT @profsmarshall: Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE read…
RT @profsmarshall: Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE read…
RT @profsmarshall: Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE read…
Up front & free to read in February's @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence w/ an AGE reader can be used in the general population to estimate the risk of #T2D, #cardiovascular disease and #mortality @umcg @bhrw @researchu
The predictive value of SAF for incident T2D, CVD and mortality. SAF significantly predicted the risk of these outcomes independently of several conventional risk factors.https://t.co/BoDRSvt3uO
Non-invasive predictor of diabetes and metabolic syndrome. Should be big but has been around over 10 years with no widespread applications. ???
"Skin autofluorescence predicted the development of type 2 diabetes, CVD and mortality, independent of several traditional risk factors, such as the metabolic syndrome, glucose and HbA1c." https://t.co/8BH0lUXts0
RT @SFDiabete: La mesure de l’autofluorescence cutanée (AGE reader) pourrait prédire dans la population générale le risque de DT2, maladie…
RT @SFDiabete: La mesure de l’autofluorescence cutanée (AGE reader) pourrait prédire dans la population générale le risque de DT2, maladie…
RT @SFDiabete: La mesure de l’autofluorescence cutanée (AGE reader) pourrait prédire dans la population générale le risque de DT2, maladie…
La mesure de l’autofluorescence cutanée (AGE reader) pourrait prédire dans la population générale le risque de DT2, maladie CV ou de mortalité (médiane de suivi : 4 ans) indépendamment des facteurs de risque classiques. #diabète https://t.co/cf7qNKn2ak
Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population | SpringerLink https://t.co/CCPeVDH2yO
Non-invasive skin autofluorescence measurement maybe of clinical value for screening for future risk of T2 diabetes, CVD & mortality https://t.co/UOcSiR51mF @IntDiabetesFed @LDC_tweets @DiabetesUK @ADA_DiabetesPro @DiabetesCanada @AmDiabetesAssn @ACCA
ref26 [Netherlands] Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Predicts 5-Year Amputation in Patients With Peripheral Artery Disease https://t.co/udzCzi6spr "in patients at lower Fontaine stage..SAF is the only marker
RT @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence with an AGE reader can be used in the general population to estimate…
RT @FocusVasculair: Skin autofluorescence (AGE reading) predicts independently the development of type 2 diabetes, CVD and mortality. https…
Skin autofluorescence (AGE reading) predicts independently the development of type 2 diabetes, CVD and mortality. https://t.co/pnuCNLbXpl
RT @DiabetologiaJnl: Non-invasive measurement of skin autofluorescence with an AGE reader can be used in the general population to estimate…
Non-invasive measurement of skin autofluorescence with an AGE reader can be used in the general population to estimate the risk of #T2D, #cardiovascular disease and #mortality: study in the Lifelines cohort. @umcg @bhrw @researchumcg 🔓 https://t.co/4T0bQ2s
And the Ancients called it an aura. It is “possible that – someday – a quick ‘autofluorescence’ light test to the skin might be used by consumers in “supermarkets, pharmacies or drugstores as a first estimate of [health] risk,” according to” researchers.ht
New Open Access! Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population https://t.co/MhhtPASgFR
RT @karinabronska: Glowing skin is associated with an increased risk of #T2D, cardiovascular disease (#CVD) and death. 73,000 adults were…
Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population - https://t.co/cTabcARFf3
https://t.co/Oc9ASq5JNV Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population #sciencenews https://t.co/mqwJq14f5C
RT @karinabronska: Glowing skin is associated with an increased risk of #T2D, cardiovascular disease (#CVD) and death. 73,000 adults were…
L'autofluorescence de la peau mettant en évidence des produits de glycation avancés (AGE) permettrait de diagnostiquer diabète et risques cardiovasculaires https://t.co/XHQsv58suq
RT @karinabronska: Glowing skin is associated with an increased risk of #T2D, cardiovascular disease (#CVD) and death. 73,000 adults were…
RT @karinabronska: Glowing skin is associated with an increased risk of #T2D, cardiovascular disease (#CVD) and death. 73,000 adults were…
Glowing skin is associated with an increased risk of #T2D, cardiovascular disease (#CVD) and death. 73,000 adults were followed up for a median of four years after their skin autofluoresence was measured using an advanced glycation endproducts reader. htt
@junte_w @telegraaf @MinOCW @MinVWS @keesvdstaaij @gertjansegers Ze hebben gekeken naar hoe de deelnemers van de grote studie er na ongeveer 4 jaar aan toe waren. Dit is een uitgebreide publicatie. https://t.co/strkdjhK8E
Skin #autofluorescence predicts incident type 2 #diabetes, cardiovascular disease and mortality in the general population https://t.co/MArGIzqOOx via @DiabetologiaJnl
RT @DiagnOptics: Landmark study about the AGE Reader in @DiabetologiaJnl. https://t.co/t5WcHfoYu7 Great work by @LifelinesNL @bhrw @umcg.
Doe de Diabetes Risico Test met de AGE Reader bij Apotheek de Vriendschap #Emmen
RT @DiagnOptics: Landmark study about the AGE Reader in @DiabetologiaJnl. https://t.co/t5WcHfoYu7 Great work by @LifelinesNL @bhrw @umcg.
Landmark study about the AGE Reader in @DiabetologiaJnl. https://t.co/t5WcHfoYu7 Great work by @LifelinesNL @bhrw @umcg.
RT @DanielJDrucker: On the road to #PrecisionMedicine #diabetes would you put your predictive $ on biomarkers, genetics, epigenetics or ski…
De paper van onderzoeker Robert van Waateringe over de AGE reader en hoe dit apparaat het ontwikkelen van diabetes en hart- en vaatziekten beter kan helpen voorspellen (onderzocht in de LifeLines studie) staat... https://t.co/36zzhqScz5
RT @bhrw: "Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population." Robert…
"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population." Robert's paper staat online. https://t.co/kpJ20zcxhK
RT @DanielJDrucker: On the road to #PrecisionMedicine #diabetes would you put your predictive $ on biomarkers, genetics, epigenetics or ski…
On the road to #PrecisionMedicine #diabetes would you put your predictive $ on biomarkers, genetics, epigenetics or skin autofluorescence @DiabetologiaJnl https://t.co/hm5C9cxVOG